PositiveID (PSID) and Siemens AG Enter Into Agreement to Expand PositiveID's Wireless Body Platform
Published: Jan 04, 2011
DELRAY BEACH, Fla., Jan. 4, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (Nasdaq:PSID), the leader in next generation patient monitoring, announced today that it has entered into an agreement with Siemens AG ("Siemens") related to its Wireless Body™ platform. The license agreement allows PositiveID to expand its personalized medicine and smart healthcare applications for next generation patient monitoring and includes granting PositiveID rights to utilize key intellectual property, and, in particular, Siemens' Patent No. 7,650,888, titled "Method and System for Identification of a Medical Implant" using RFID (radio frequency identification).